Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Finasteride may cause long-lasting sexual side effects.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Vitamin D3 affects cell differentiation in specific skin areas.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Both mouse and rat models are effective for testing alopecia areata treatments.

SHBG may be a useful early indicator and treatment target for PCOS.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.